AlphaFold predicted structure
ERLIN2 · O94905

Mean pLDDT
85.1/ 100
Confident
339 residues
Confidence breakdown
- Very high(≥ 90)69%
- Confident(70–90)17%
- Low(50–70)3%
- Very low(< 50)11%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
ER lipid raft associated 2
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Adult onset hereditary spastic paraplegia
BOTH monoallelic and biallelic, autosomal or pseudoautosomalChildhood onset hereditary spastic paraplegia
BOTH monoallelic and biallelic, autosomal or pseudoautosomalHereditary spastic paraplegia
BOTH monoallelic and biallelic, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalAdult onset neurodegenerative disorder
BOTH monoallelic and biallelic, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalhereditary spastic paraplegia 18
Autosomal recessive spastic paraplegia type 18
hereditary spastic paraplegia
spastic paraplegia 18b, autosomal recessive
cancer
autosomal dominant complex spastic paraplegia
bone development disease
Spastic paraplegia
Neurodegeneration
neurodegenerative disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Erlin-2
Component of the ERLIN1/ERLIN2 complex which mediates the endoplasmic reticulum-associated degradation (ERAD) of inositol 1,4,5-trisphosphate receptors (IP3Rs) such as ITPR1 (PubMed:17502376, PubMed:19240031). Promotes sterol-accelerated ERAD of HMGCR probably implicating an AMFR/gp78-containing ubiquitin ligase complex (PubMed:21343306). Involved in regulation of cellular cholesterol homeostasis by regulation the SREBP signaling pathway. May promote ER retention of the SCAP-SREBF complex (PubMed:24217618)
Curated MONDO disease pages that list ERLIN2 among their top associated genes.
ERLIN2 · O94905

Mean pLDDT
85.1/ 100
Confident
339 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0